Stay updated on Avelumab in Chemo-resistant GTN Clinical Trial
Sign up to get notified when there's something new on the Avelumab in Chemo-resistant GTN Clinical Trial page.

Latest updates to the Avelumab in Chemo-resistant GTN Clinical Trial page
- Check5 days agoChange DetectedThe site revision label was updated from v3.5.3 to v3.5.4, indicating a new release of the page UI. This update does not modify the study content, eligibility criteria, locations, or outcomes shown.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe page’s displayed revision/version was updated from v3.5.2 to v3.5.3, reflecting a change to the site’s interface/versioning rather than the underlying clinical trial information.SummaryDifference0.1%

- Check34 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check62 days agoChange Detected- Revision tag updated from v3.4.3 to v3.5.0, indicating a minor update. No changes to study details or eligibility information were observed.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check99 days agoChange DetectedRevision label updated to v3.4.2 (replacing v3.4.1); no study details, eligibility criteria, results, or other core content were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Avelumab in Chemo-resistant GTN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab in Chemo-resistant GTN Clinical Trial page.